References
- Fujimaki M., Hakusui H. Studies on the metabolic fate of carvedilol (III). Biliary excretion and enterohepatic circulation in rats. Xenobiotic Metabolism and Disposition 1989; 4(6)667–671
- Fujimaki M., Shintani S., Hakusui H. Studies on the metabolic fate of carvedilol (VI). Absorption, excretion and distribution in monkeys. Xenobiotic Metabolism and Disposition 1989; 4(6)693–701
- Hakusui H., Fujimaki M., Esumi Y., Takaichi M., Saito S., Otsuki M., Miyake T., Honda S. Studies on the metabolic fate of carvedilol (I). Pharmacokinetics in the rat following a single oral dose. Xenobiotic Metabolism and Disposition 1989; 4(6)637–649
- Neubert P. Metabolism of carvedilol in dogs. Boehringer Mannheim Investigation Report 1986
- Neugebauer G., Akpan W., Möllendorff E. v., Neubert P., Reiff K. Pharmacokinetics and disposition of carvedilol in humans. Journal of Cardiovascular Pharmacology 1987; 10: S85–S88, (Suppl. 11)
- Schmidt H. High pressure liquid chromatography of the carvedilol enantiomers. Boehringer Mannheim Investigation Report 1987
- Sponer G., Bartsch W., Strein K., Müller-Beckmann B., Böhm E. Pharmacological profile of carvedilol as a β-blocking agent with vasodilating and hypotensive properties. Journal of Cardiovascular Pharmacology 1987; 9: 317–327